Compounds > tranexamic acid
Page last updated: 2024-11-05

tranexamic acid and Blood Clot

tranexamic acid has been researched along with Blood Clot in 104 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research Excerpts

ExcerptRelevanceReference
"The combined application of tranexamic acid and rivaroxaban significantly reduced the amount of blood loss and the transfusion rate during PLIF surgery and avoided an increase in the probability of thrombosis and the occurrence of epidural haematoma."9.34Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial. ( Chen, Y; Guan, T; Jiao, G; Li, Y; Liu, D; Liu, H; Meng, C; Sun, Z; Wang, H; Wu, W; Xiao, X; Xue, H; Yue, H; Zhang, L; Zhou, H, 2020)
" The CRASH-2 trial aimed to determine the effect of the early administration of tranexamic acid on death and transfusion requirement in bleeding trauma patients."9.17The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. ( Balogun, E; Barnetson, L; Cairns, J; Coats, T; Cook, L; Guerriero, C; Hunt, B; Kawahara, T; Perel, P; Prieto-Merino, D; Ramos, M; Roberts, I; Shakur, H, 2013)
"Tranexamic acid was associated with a significant reduction in all cause mortality and deaths from bleeding."9.16Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. ( Brohi, K; Coats, T; Hunt, BJ; Lecky, F; Perel, P; Prieto-Merino, D; Roberts, I; Shakur, H; Willett, K, 2012)
"There has been an explosion of interest in the ability of tranexamic acid to reduce morbidity and mortality in surgical and traumatic bleeding."8.91The current place of tranexamic acid in the management of bleeding. ( Hunt, BJ, 2015)
"Tranexamic acid, an antifibrinolytic agent, reduces postoperative transfusion requirements but carries a poorly documented risk of thrombosis."8.89Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality. ( , 2013)
"This case reminds clinicians that perioperative tranexamic acid administration may increase the risk of thrombosis, which needs focused attention from anesthesiologists."8.02Circulation collapse caused by intracardiac thrombosis associated with tranexamic acid administration: A case report. ( Gu, KP; Huang, CJ; Xie, Q; Yao, YX, 2021)
"We describe the case of a bleeding trauma patient who received tranexamic acid (TXA) during air transport who subsequently developed multiple intra-cardiac thrombi."7.88Left atrial thrombi following tranexamic acid in a bleeding trauma patient-A word of caution. ( Carroll, ND; Eastridge, BJ; Restrepo, CS; Stasik, CN, 2018)
"Infarct-type necrosis and thrombosis of leiomyoma was more commonly observed in patients treated with tranexamic acid."7.74Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas. ( Chan, QK; Cheung, AN; Cheung, CL; Ip, PP; Lam, KW; Pun, TC; Yeung, MC, 2007)
"Further to characterize the processes involved in the FeCl3-induced thrombosis model, we determined the effect of aspirin, heparin, hirudin, trans-4-(aminomethyl) cyclohexane carboxylic acid (AMCHA), thrombocytopenia, and flow modifications on time to occlusion (TTO) and thrombus weight (TW) in the rat carotid artery."7.70Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. ( Kambayashi, J; Lockyer, S, 1999)
"Compared to the CRASH-2 trial, adult trauma patients receiving TXA identified in our systematic review had a lower incidence of mortality at 28 or 30 days, but a higher incidence of in-hospital thrombotic events."6.61Mortality and Thrombosis in Injured Adults Receiving Tranexamic Acid in the Post-CRASH-2 Era. ( Benipal, S; Nishijima, DK; Santamarina, JL; Vo, L, 2019)
"Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo."5.51Tranexamic Acid in Patients Undergoing Noncardiac Surgery. ( Aguado, HJ; Alfonsi, P; Amir, M; Astrakov, SV; Balasubramanian, K; Bangdiwala, SI; Belley-Côté, EP; Bhatt, K; Borges, FK; Cafaro, T; Chan, MTV; Conen, D; Copland, I; de Nadal, M; Devereaux, PJ; Duceppe, E; Efremov, S; Eikelboom, J; Fleischmann, E; Garg, AX; Gross, PL; Guyatt, G; Kleinlugtenbelt, YV; Lamy, A; Landoni, G; Leslie, K; Likhvantsev, VV; Lomivorotov, V; Marcucci, M; Martínez-Zapata, MJ; McGillion, MH; McIntyre, W; Meyhoff, CS; Ofori, SN; Painter, TW; Paniagua, P; Parlow, JL; Patel, A; Polanczyk, CA; Prystajecky, M; Rao, M; Richards, T; Roshanov, PS; Ruetzler, K; Schmartz, D; Sessler, DI; Short, TG; Spence, J; Stillo, D; Szczeklik, W; Tandon, V; Torres, D; Turan, A; VanHelder, T; Vincent, J; Wang, CY; Wang, MK; Whitlock, RP; Wittmann, M; Wu, WKK; Xavier, D; Yusuf, S, 2022)
"Pediatric craniosynostosis repair with cranial vault reconstructive surgery can be associated with significant blood loss."5.51Ulnar Artery Thrombosis Following Tranexamic Acid Administration for Craniosynostosis Repair. ( Chung, E; Karlberg, HI, 2019)
"Post-TXA MI was more often STEMI caused by arterial thrombosis, rather than non-STEMI caused by blood loss, hypotension or demand ischaemia."5.51Acute ST-elevation myocardial infarction due to in-stent thrombosis after administering tranexamic acid in a high cardiac risk patient. ( Kaptein, YE, 2019)
"The combined use of intraarticular topical TXA with rivaroxaban in patients undergoing TKA is a safe and effective method to reduce blood loss, the need for transfusion, and wound complications without elevating the risk of DVT."5.48Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis. ( Kang, MW; Kim, JI; Kim, YT; Lee, JK; Lee, YM, 2018)
"But when bleeding is not life-threatening, the thrombotic risk is too poorly documented to justify exposing patients to a plausible and inadequately evaluated risk."5.39Tranexamic acid and thrombosis. ( , 2013)
"The combined application of tranexamic acid and rivaroxaban significantly reduced the amount of blood loss and the transfusion rate during PLIF surgery and avoided an increase in the probability of thrombosis and the occurrence of epidural haematoma."5.34Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial. ( Chen, Y; Guan, T; Jiao, G; Li, Y; Liu, D; Liu, H; Meng, C; Sun, Z; Wang, H; Wu, W; Xiao, X; Xue, H; Yue, H; Zhang, L; Zhou, H, 2020)
"Tranexamic acid reduces the risk of bleeding among patients undergoing cardiac surgery, but it is unclear whether this leads to improved outcomes."5.24Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. ( Bussières, JS; Byrne, K; Chan, MT; Cooper, DJ; Forbes, A; Jayarajah, M; Landoni, G; Marasco, S; McGuinness, S; McNeil, J; Myles, PS; Painter, T; Silbert, B; Smith, JA; Wallace, S, 2017)
" The CRASH-2 trial aimed to determine the effect of the early administration of tranexamic acid on death and transfusion requirement in bleeding trauma patients."5.17The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. ( Balogun, E; Barnetson, L; Cairns, J; Coats, T; Cook, L; Guerriero, C; Hunt, B; Kawahara, T; Perel, P; Prieto-Merino, D; Ramos, M; Roberts, I; Shakur, H, 2013)
"Tranexamic acid was associated with a significant reduction in all cause mortality and deaths from bleeding."5.16Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. ( Brohi, K; Coats, T; Hunt, BJ; Lecky, F; Perel, P; Prieto-Merino, D; Roberts, I; Shakur, H; Willett, K, 2012)
" 20 211 adult trauma patients with, or at risk of, significant bleeding were randomly assigned within 8 h of injury to either tranexamic acid (loading dose 1 g over 10 min then infusion of 1 g over 8 h) or matching placebo."5.14Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. ( Bautista, R; Caballero, J; Coats, T; Dewan, Y; El-Sayed, H; Gogichaishvili, T; Gupta, S; Herrera, J; Hunt, B; Iribhogbe, P; Izurieta, M; Khamis, H; Komolafe, E; Marrero, MA; Mejía-Mantilla, J; Miranda, J; Morales, C; Olaomi, O; Olldashi, F; Perel, P; Peto, R; Ramana, PV; Ravi, RR; Roberts, I; Shakur, H; Yutthakasemsunt, S, 2010)
"There has been an explosion of interest in the ability of tranexamic acid to reduce morbidity and mortality in surgical and traumatic bleeding."4.91The current place of tranexamic acid in the management of bleeding. ( Hunt, BJ, 2015)
" The aim of this study was to review the literature on the use of lysine analogs to prevent bleeding and blood transfusion during pelvic surgery."4.90The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis. ( Beck, A; Breau, RH; Buenaventura, C; Cagiannos, I; Cowan, J; Fergusson, DA; Knoll, G; Kokolo, MB; Momoli, F; Morash, C; Niznick, N; Punjani, N; Ruzicka, M; Schachkina, S; Tinmouth, A; Xie, HY, 2014)
"Tranexamic acid, an antifibrinolytic agent, reduces postoperative transfusion requirements but carries a poorly documented risk of thrombosis."4.89Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality. ( , 2013)
"We sought trials or observational studies of ≥20 adults involving any antifibrinolytic drug (TXA, epsilonaminocaproic acid (EACA) or aprotinin) for spontaneous (non-traumatic, non-surgical/iatrogenic), non-heamophiliac bleeding."4.88The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials. ( Al-Shahi Salman, R; Ross, J, 2012)
" Tranexamic acid (TXA) reduces the proteolytic action of plasmin on fibrin clots, resulting in an inhibition of fibrinolysis and stabilisation of established blood clots."4.12The role of tranexamic acid in traumatic brain injury. ( Ho, KM; Honeybul, S; Rosenfeld, JV, 2022)
"Within 2245 included ICSRs on tranexamic acid, we identified 29 reports of adverse renal vascular and ischemic conditions, 42 reports of pulmonary thrombotic and embolic conditions, and 41 reports of peripheral embolism and thrombosis."4.02Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data. ( Burden, AM; Heesen, M; Stämpfli, D; Weiler, S; Weiniger, CF, 2021)
"This case reminds clinicians that perioperative tranexamic acid administration may increase the risk of thrombosis, which needs focused attention from anesthesiologists."4.02Circulation collapse caused by intracardiac thrombosis associated with tranexamic acid administration: A case report. ( Gu, KP; Huang, CJ; Xie, Q; Yao, YX, 2021)
"Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits fibrinolysis by blocking lysine-binding sites on plasminogen, which contribute to reduced bleeding, the need for transfusion and mortality."3.96Safety of tranexamic acid in thrombotic adverse events and seizure in patients with haemorrhage: a protocol for a systematic review and meta-analysis. ( Murao, S; Nakata, H; Yamakawa, K, 2020)
"We describe the case of a bleeding trauma patient who received tranexamic acid (TXA) during air transport who subsequently developed multiple intra-cardiac thrombi."3.88Left atrial thrombi following tranexamic acid in a bleeding trauma patient-A word of caution. ( Carroll, ND; Eastridge, BJ; Restrepo, CS; Stasik, CN, 2018)
"Infarct-type necrosis and thrombosis of leiomyoma was more commonly observed in patients treated with tranexamic acid."3.74Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas. ( Chan, QK; Cheung, AN; Cheung, CL; Ip, PP; Lam, KW; Pun, TC; Yeung, MC, 2007)
"Further to characterize the processes involved in the FeCl3-induced thrombosis model, we determined the effect of aspirin, heparin, hirudin, trans-4-(aminomethyl) cyclohexane carboxylic acid (AMCHA), thrombocytopenia, and flow modifications on time to occlusion (TTO) and thrombus weight (TW) in the rat carotid artery."3.70Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. ( Kambayashi, J; Lockyer, S, 1999)
"Tranexamic acid has been advocated for patients with severe bleeding tendency due to thrombocytopenia not responding to platelet transfusions."3.69Microscopic haematuria as a relative contraindication for tranexamic acid. ( Schultz, M; van der Lelie, H, 1995)
" Prophylaxis against angioneurotic oedema using danazol and tranexamic acid is described and the resultant complication of mesenteric venous thrombosis reported."3.67Acquired C1 esterase inhibitor deficiency. ( Coulson, IH; Findley, IL; Gould, TR; Razis, PA, 1986)
"To compare the efficacy and adverse events of high-dose vs low-dose tranexamic acid in patients undergoing cardiac surgery with cardiopulmonary bypass."3.11Effect of High- vs Low-Dose Tranexamic Acid Infusion on Need for Red Blood Cell Transfusion and Adverse Events in Patients Undergoing Cardiac Surgery: The OPTIMAL Randomized Clinical Trial. ( Cheng, Z; Feng, W; Liu, S; Pan, W; Shi, J; Sun, H; Wang, W; Wang, Y; Zheng, Z; Zhou, C, 2022)
" Potential benefits and possible risks should be trade-off when considering increasing the dosage and frequency of TXA on the present basis."2.90Application of thrombelastography (TEG) for safety evaluation of tranexamic acid in primary total joint arthroplasty. ( Chen, C; Chen, Y; Cheng, Q; He, Y; Huang, W; Liu, W; Tao, YZ; Tian, M; Wu, XD; Xu, W, 2019)
"No deep venous thrombosis or other severe complications had occurred."2.84Intra-articular Application is More Effective Than Intravenous Application of Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial. ( Wang, J; Wang, Q; Zhang, X, 2017)
" However, in infants less than 1 year of age, the optimal dosing based on pharmacokinetic (PK) considerations is still under discussion."2.84Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery. ( Braun, S; Burg, S; Gertler, R; Grassin-Delyle, S; Gruber, M; Martin, K; Tassani-Prell, P; Urien, S; Wiesner, G, 2017)
"Tranexamic acid is a simple means of reducing postoperative blood loss in THR, without increased risk of thromboembolism when associated to rivaroxaban thromboprophylaxis."2.77Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients. ( Clavé, A; Dumser, D; Fazilleau, F; Lacroix, J, 2012)
"Tranexamic acid was found as effective as aprotinin on platelets function."2.67[The use of antifibrinolytics in heart surgery. 3 prospective studies]. ( Benmosbah, L; Boughenou, F; Cousin, MT; Madi-Jebara, S; Massonnet-Vastel, S, 1993)
"Compared to the CRASH-2 trial, adult trauma patients receiving TXA identified in our systematic review had a lower incidence of mortality at 28 or 30 days, but a higher incidence of in-hospital thrombotic events."2.61Mortality and Thrombosis in Injured Adults Receiving Tranexamic Acid in the Post-CRASH-2 Era. ( Benipal, S; Nishijima, DK; Santamarina, JL; Vo, L, 2019)
" Dosage adjustment of TXA is essential in CKD patients."2.55Manifestation of tranexamic acid toxicity in chronic kidney disease and kidney transplant patients: A report of four cases and review of literature. ( Chow, KM; Kwan, BC; Leung, CB; Li, PK; Ma, TK; Szeto, CC, 2017)
"Perioperative prophylactic treatment for high-bleeding-risk surgery in patients with severe FXI deficiency is based on fresh frozen plasma (FFP) transfusions or FXI concentrate (where available)."1.91[PERIOPERATIVE MANAGEMENT OF AN ADOLESCENT GIRL WITH SEVERE FACTOR XI DEFICIENCY AND INHIBITORS]. ( Berger-Achituv, S; Keren-Politansky, A; Mandel-Shorer, N; Oren-Malek, L; Revel-Vilk, S, 2023)
"Tranexamic acid (TXA) has been shown to reduce blood loss and transfusion risk in various orthopedic surgeries including shoulder arthroplasty."1.62Administration of tranexamic acid during total shoulder arthroplasty is not associated with increased risk of complications in patients with a history of thrombotic events. ( Cagle, PJ; Carbone, A; Chan, J; Galatz, LM; Mazumdar, M; Parsons, BO; Poeran, J; Zubizarreta, N, 2021)
"4F-PCC-induced thrombus formation was lower after haemodilution versus non-haemodilution."1.62Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models. ( Dickneite, G; Doerr, B; Ghosh, S; Herzog, E; Krege, W; Mischnik, M; Pragst, I, 2021)
"The results of a test of the total thrombus-formation analysis system showed improved blood clot formation ability."1.56Effect of Tranexamic Acid for Traumatic Brain Injury: A Case Report. ( Inoue, S; Miike, T; Sakamoto, Y, 2020)
"Post-TXA MI was more often STEMI caused by arterial thrombosis, rather than non-STEMI caused by blood loss, hypotension or demand ischaemia."1.51Acute ST-elevation myocardial infarction due to in-stent thrombosis after administering tranexamic acid in a high cardiac risk patient. ( Kaptein, YE, 2019)
"Pediatric craniosynostosis repair with cranial vault reconstructive surgery can be associated with significant blood loss."1.51Ulnar Artery Thrombosis Following Tranexamic Acid Administration for Craniosynostosis Repair. ( Chung, E; Karlberg, HI, 2019)
" A single very low dose of rFVIIa along with TXA is a simple and safe treatment to control hemostasis in severe FXI-deficient patients undergoing diverse type of surgical procedure at various sites."1.51Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery. ( Avishai, E; Bashari, D; Budnik, I; Dardik, R; Livnat, T; Salomon, O; Tamarin, I, 2019)
"The combined use of intraarticular topical TXA with rivaroxaban in patients undergoing TKA is a safe and effective method to reduce blood loss, the need for transfusion, and wound complications without elevating the risk of DVT."1.48Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis. ( Kang, MW; Kim, JI; Kim, YT; Lee, JK; Lee, YM, 2018)
"Tranexamic acid (TXA) is a common antifibrinolytic agent used to minimize bleeding in cardiac surgery."1.48Tranexamic Acid Dosing for Cardiac Surgical Patients With Chronic Renal Dysfunction: A New Dosing Regimen. ( Beattie, WS; Bojko, B; Jerath, A; Looby, N; Pang, KS; Pawliszyn, J; Reyes-Garces, N; Vasiljevic, T; Wąsowicz, M; Wijeysundera, D; Yang, QJ; Yau, TM, 2018)
"The bleeding propensity in von Willebrand disease (VWD) is usually moderate or mild and patients with VWD do not need continuous treatment, but do require extra increased haemostatic cover when undergoing dental or surgical procedures."1.43Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey. ( Altisent, C; Dolan, G; Katsarou, O; López Fernández, MF; Windyga, J; Zülfikar, B, 2016)
"Tranexamic acid (TXA) is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin."1.42TXA in combat casualty care--does it adversely affect extremity reconstruction and flap thrombosis rates? ( Campbell, P; Fleming, M; Jessie, E; Lucas, DJ; Rodriguez, C; Sabino, J; Valerio, IL, 2015)
"But when bleeding is not life-threatening, the thrombotic risk is too poorly documented to justify exposing patients to a plausible and inadequately evaluated risk."1.39Tranexamic acid and thrombosis. ( , 2013)
"Defective hemostasis in haemophilia patients with FVIII inhibitors results in a dramatic decrease in thrombin generation forming unstable fibrin clots that are susceptible to fibrinolyisis."1.37Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma. ( Bevan, D; Dai, L; Mitchell, M; Rangarajan, S; Sørensen, B, 2011)
"Pain control; eight different types of postoperative pain relief were utilized across the centres, some in isolation but many in combination."1.37Blood conservation and pain control in scoliosis corrective surgery: an online survey of UK practice. ( Bird, S; McGill, N, 2011)
"However, thrombosis has occurred in three of 12 such patients."1.35Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies. ( Bar-Zakay, B; Horowitz, Z; Korianski, Y; Livnat, T; Mor, Y; Salomon, O; Seligsohn, U; Tamarin, I; Winckler, H, 2009)
"Aprotinin inhibited thrombus formation in vivo in a dose-dependent manner (minimal effective dose, 3 mg kg(-1) bolus plus 6 mg kg(-1) h(-1) infusion)."1.34Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation. ( Huetter, J; Sperzel, M, 2007)
"Platelet-rich thrombus formation (occlusion time) was dose-dependently inhibited by monoclonal antibody against platelet glycoprotein (GP) Ib (6B4 and 12E4), aurin tricarboxylic acid, monoclonal antibody against platelet GPIIb/IIIa (MA-16N7C2 and abciximab), a synthetic GPIIb/IIIa antagonist (TAK-029), thrombin inhibitor (argatroban), and anti-von Willebrand factor, but not by anti-fibrinogen."1.32Görög Thrombosis Test: a global in-vitro test of platelet function and thrombolysis. ( Hashimoto, M; Ikarugi, H; Ishii, H; Kovacs, IB; Taka, T; Watanabe, S; Yamamoto, J; Yamashita, T, 2003)
"Thus, arterial occlusion caused by a thrombus arising at arterial bifurcations may be prolonged because of enlargement of the thrombus owing to the action of platelets in blood flowing through the intact branch."1.30Prolonged arterial occlusion caused by thrombus development at sites of arterial bifurcation. ( Araki, H; Ishihara, N, 1997)

Research

Studies (104)

TimeframeStudies, this research(%)All Research%
pre-19903 (2.88)18.7374
1990's13 (12.50)18.2507
2000's13 (12.50)29.6817
2010's47 (45.19)24.3611
2020's28 (26.92)2.80

Authors

AuthorsStudies
Sperzel, M1
Huetter, J1
Ghosh, S1
Krege, W1
Doerr, B1
Mischnik, M1
Pragst, I1
Dickneite, G1
Herzog, E1
Xie, Q1
Huang, CJ1
Gu, KP1
Yao, YX1
Maresca, G1
Royle, J1
Donaldson, JF1
Honeybul, S1
Ho, KM1
Rosenfeld, JV1
Devereaux, PJ1
Marcucci, M1
Painter, TW1
Conen, D1
Lomivorotov, V1
Sessler, DI1
Chan, MTV1
Borges, FK1
Martínez-Zapata, MJ1
Wang, CY1
Xavier, D1
Ofori, SN1
Wang, MK1
Efremov, S1
Landoni, G2
Kleinlugtenbelt, YV1
Szczeklik, W1
Schmartz, D1
Garg, AX1
Short, TG1
Wittmann, M1
Meyhoff, CS1
Amir, M1
Torres, D1
Patel, A1
Duceppe, E1
Ruetzler, K1
Parlow, JL1
Tandon, V1
Fleischmann, E1
Polanczyk, CA1
Lamy, A1
Astrakov, SV1
Rao, M1
Wu, WKK1
Bhatt, K1
de Nadal, M1
Likhvantsev, VV1
Paniagua, P1
Aguado, HJ1
Whitlock, RP1
McGillion, MH1
Prystajecky, M1
Vincent, J1
Eikelboom, J1
Copland, I1
Balasubramanian, K1
Turan, A1
Bangdiwala, SI1
Stillo, D1
Gross, PL1
Cafaro, T1
Alfonsi, P1
Roshanov, PS1
Belley-Côté, EP1
Spence, J1
Richards, T2
VanHelder, T1
McIntyre, W1
Guyatt, G1
Yusuf, S1
Leslie, K1
Gadomski, J1
Zawadka, M1
Shi, J1
Zhou, C1
Pan, W1
Sun, H1
Liu, S1
Feng, W1
Wang, W2
Cheng, Z1
Wang, Y2
Zheng, Z1
Lynham, R1
Preissler, S1
Lightfoot, NJ1
Coates, J1
Mandel-Shorer, N1
Oren-Malek, L1
Keren-Politansky, A1
Berger-Achituv, S1
Revel-Vilk, S1
Alsabani, MH1
Sibai, A1
Alharbi, SF1
Olayan, LH1
Samman, AA1
Al Harbi, MK1
Morkos, K1
Maingard, J1
Barras, C1
Kok, HK1
Hall, J1
Russell, J1
Thijs, V1
Slater, LA1
Chong, W1
Chandra, R1
Jhamb, A1
Brooks, M1
Asadi, H1
Hines, EM1
Clement, I1
Cheng, SF1
Bao, W1
Zhou, J1
Wang, J2
Chu, M1
Salomon, O2
Budnik, I1
Avishai, E1
Tamarin, I2
Bashari, D1
Dardik, R1
Livnat, T2
Barzilai, M1
Kirgner, I1
Steimatzky, A1
Salzer Gotler, D1
Belnick, Y1
Shacham-Abulafia, A1
Avivi, I1
Raanani, P1
Yahalom, V1
Nakav, S1
Varon, D1
Yussim, E1
Bachar, GN1
Spectre, G1
Zehtabchi, S1
Bolliger, D2
Tanaka, KA2
Fenger-Eriksen, C1
Lindholm, AD1
Krogh, L1
Hell, T1
Berger, M1
Hermann, M1
Fries, D1
Juul, N1
Rasmussen, M1
Hvas, AM1
Miike, T1
Sakamoto, Y1
Inoue, S1
Murao, S1
Nakata, H1
Yamakawa, K1
Kaiser, P1
Zuckermann, A1
Horvat, J1
Lederer, F1
Gisslinger, H1
Gremmel, F1
Simon, P1
Wiedemann, D1
Andreas, M1
Zhang, L2
Li, Y2
Liu, D2
Xiao, X1
Guan, T1
Yue, H1
Xue, H1
Zhou, H1
Jiao, G2
Wu, W2
Wang, H2
Liu, H2
Meng, C1
Sun, Z1
Chen, Y3
Carbone, A1
Poeran, J1
Zubizarreta, N1
Chan, J1
Mazumdar, M1
Parsons, BO1
Galatz, LM1
Cagle, PJ1
Nelson Yap, KB1
Albert Wong, SH1
Idris, Z1
Stämpfli, D1
Weiler, S1
Weiniger, CF1
Burden, AM1
Heesen, M1
Zhang, D1
Wu, H1
Kong, Q1
Keragala, CB1
Medcalf, RL1
Dong, H1
Lu, Y1
Luo, Y1
Hajmurad, OS1
Choxi, AA1
Zahid, Z1
Dudaryk, R1
Wang, Q2
Zhang, X1
Samson, AL1
Alwis, I1
Maclean, JAA1
Priyananda, P1
Hawkett, B1
Schoenwaelder, SM1
Jackson, SP1
Dai, Z1
Chu, H1
Wang, S1
Liang, Y1
Shimauchi, T1
Yamaura, K1
Higashi, M1
Abe, K1
Yoshizumi, T1
Hoka, S1
Duan, K1
Ma, M1
Jiang, Y1
Liu, T1
Liu, J1
Hao, D1
Jerath, A1
Yang, QJ1
Pang, KS1
Looby, N1
Reyes-Garces, N1
Vasiljevic, T1
Bojko, B1
Pawliszyn, J1
Wijeysundera, D1
Beattie, WS1
Yau, TM1
Wąsowicz, M1
Carroll, ND1
Restrepo, CS1
Eastridge, BJ1
Stasik, CN1
Schiavone, A1
Bisaccia, M1
Inkov, I1
Rinonapoli, G1
Manni, M1
Rollo, G1
Meccariello, L1
Vicente, CI1
Ceccarini, P1
Ruggiero, C1
Caraffa, A1
Kim, YT1
Kang, MW1
Lee, JK1
Lee, YM1
Kim, JI1
Godbey, EA1
Schwartz, J1
Chung, E1
Karlberg, HI1
Hawkins, RB1
Mehaffey, JH1
Saracoglu, A1
Ezelsoy, M1
Saracoglu, KT1
Kaptein, YE1
Chornenki, NLJ1
Um, KJ1
Mendoza, PA1
Samienezhad, A1
Swarup, V1
Chai-Adisaksopha, C1
Siegal, DM1
Benipal, S1
Santamarina, JL1
Vo, L1
Nishijima, DK1
Wu, XD1
Tian, M1
He, Y1
Tao, YZ1
Xu, W1
Cheng, Q1
Chen, C1
Liu, W1
Huang, W1
Long, B1
April, MD1
Roberts, I3
Shakur, H3
Coats, T3
Hunt, B2
Balogun, E1
Barnetson, L1
Cook, L1
Kawahara, T1
Perel, P3
Prieto-Merino, D2
Ramos, M1
Cairns, J1
Guerriero, C1
Muñoz Gómez, M1
Páramo Fernández, JA1
Gruen, RL1
Jacobs, IG1
Reade, MC1
Meurer, WJ1
Breau, RH1
Kokolo, MB1
Punjani, N1
Cagiannos, I1
Beck, A1
Niznick, N1
Buenaventura, C1
Cowan, J1
Knoll, G1
Momoli, F1
Morash, C1
Ruzicka, M1
Schachkina, S1
Tinmouth, A1
Xie, HY1
Fergusson, DA1
Schwameis, M1
Thaler, J1
Schober, A1
Schörgenhofer, C1
Kulinna-Cosentini, C1
Laggner, A1
Röggla, M1
Jilma, B1
Hunt, BJ2
Hourlier, H1
Reina, N1
Fennema, P1
Valerio, IL1
Campbell, P1
Sabino, J1
Lucas, DJ1
Jessie, E1
Rodriguez, C1
Fleming, M1
Gerstein, NS2
Brierley, JK2
Culling, MD1
Ma, TK1
Chow, KM1
Kwan, BC1
Leung, CB1
Szeto, CC1
Li, PK1
Kelly, SP1
Windyga, J1
Dolan, G1
Altisent, C1
Katsarou, O1
López Fernández, MF1
Zülfikar, B1
Myles, PS1
Smith, JA1
Forbes, A1
Silbert, B1
Jayarajah, M1
Painter, T1
Cooper, DJ1
Marasco, S1
McNeil, J1
Bussières, JS1
McGuinness, S1
Byrne, K1
Chan, MT1
Wallace, S1
Gertler, R1
Gruber, M1
Grassin-Delyle, S1
Urien, S1
Martin, K1
Tassani-Prell, P1
Braun, S1
Burg, S1
Wiesner, G1
Mor, Y1
Winckler, H1
Horowitz, Z1
Korianski, Y1
Bar-Zakay, B1
Seligsohn, U1
Ide, M1
Taketomi, T1
Bautista, R1
Caballero, J1
Dewan, Y1
El-Sayed, H1
Gogichaishvili, T1
Gupta, S1
Herrera, J1
Iribhogbe, P1
Izurieta, M1
Khamis, H1
Komolafe, E1
Marrero, MA1
Mejía-Mantilla, J1
Miranda, J1
Morales, C1
Olaomi, O1
Olldashi, F1
Peto, R1
Ramana, PV1
Ravi, RR1
Yutthakasemsunt, S1
Yeguiayan, JM1
Rosencher, N1
Freysz, M1
Bird, S1
McGill, N1
Dai, L1
Bevan, D1
Rangarajan, S1
Sørensen, B1
Mitchell, M1
Weightman, WM1
Gibbs, NM1
Clavé, A1
Fazilleau, F1
Dumser, D1
Lacroix, J1
Ross, J2
Al-Shahi Salman, R1
Lecky, F1
Brohi, K1
Willett, K1
Pusateri, AE1
Weiskopf, RB1
Bebarta, V1
Butler, F1
Cestero, RF1
Chaudry, IH1
Deal, V1
Dorlac, WC1
Gerhardt, RT1
Given, MB1
Hansen, DR1
Hoots, WK1
Klein, HG1
Macdonald, VW1
Mattox, KL1
Michael, RA1
Mogford, J1
Montcalm-Smith, EA1
Niemeyer, DM1
Prusaczyk, WK1
Rappold, JF1
Rassmussen, T1
Rentas, F1
Thompson, C1
Tucker, LD1
Yamamoto, J3
Yamashita, T2
Ikarugi, H2
Taka, T1
Hashimoto, M2
Ishii, H2
Watanabe, S1
Kovacs, IB1
Oiwa, K1
Matsuo, O1
Ueshima, S1
Okada, K1
Okada, Y2
Okamoto, S1
Giddings, JC1
Levin, MD1
Betjes, MG1
V d Kwast, TH1
Wenberg, BL1
Leebeek, FW1
Casati, V1
Pleym, H1
Stenseth, R1
Wahba, A1
Bjella, L1
Karevold, A1
Dale, O1
Inoue, A1
Tsuda, Y1
Body, SC1
Mazer, CD1
Molenaar, IQ1
Warnaar, N1
Groen, H1
Tenvergert, EM1
Slooff, MJ1
Porte, RJ1
Ip, PP1
Lam, KW1
Cheung, CL1
Yeung, MC1
Pun, TC1
Chan, QK1
Cheung, AN1
Tanaka, N1
Ogawa, H1
Kinjo, M1
Kohga, S1
Tanaka, K1
Cousin, MT1
Boughenou, F1
Madi-Jebara, S1
Massonnet-Vastel, S1
Benmosbah, L1
Royston, D2
Zhang, B2
Wieslander, JB3
Schultz, M1
van der Lelie, H1
Krishnamurti, C1
Vukelja, SJ1
Alving, BM1
Abrahamsson, T1
Nerme, V1
Strömqvist, M1
Akerblom, B1
Legnehed, A1
Pettersson, K1
Westin Eriksson, A1
Araki, H1
Ishihara, N1
Lockyer, S1
Kambayashi, J1
Williams, GD1
Ramamoorthy, C1
Brown, JE1
Olujohungbe, A1
Chang, J1
Ryder, WD1
Morganstern, GR1
Chopra, R1
Scarffe, JH1
Dalmau, A1
Sabaté, A1
Koo, M1
Rafecas, A1
Figueras, J1
Jaurrieta, E1
Coeugniet, E1
Arnljots, B1
Dougan, P1
Salemark, L1
Békássy, Z1
Astedt, B1
Razis, PA1
Coulson, IH1
Gould, TR1
Findley, IL1

Clinical Trials (38)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
PeriOperative ISchemic Evaluation-3 Trial[NCT03505723]Phase 39,535 participants (Actual)Interventional2018-06-27Completed
Outcome Impact of Different Tranexamic Acid Regimen in Cardiac Surgery With Cardiopulmonary Bypass (the OPTIMAL Study)[NCT03782350]Phase 43,079 participants (Actual)Interventional2018-12-26Completed
Pharmacokinetics of Tranexamic Acid in Patients With Varying Renal Function Undergoing Cardiac Surgery With the Use of Cardiopulmonary Bypass[NCT01609686]49 participants (Actual)Observational2012-01-31Completed
Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery: A Double-Blind Randomized Controlled Trial[NCT04863339]Phase 20 participants (Actual)Interventional2022-03-31Withdrawn (stopped due to Challenges in recruitment)
Randomized Study on the Topical Application of Tranexamic Acid to Wound Bed for Hemostasis in the Setting Granulating Wounds Following Mohs Micrographic Surgery[NCT04541303]Early Phase 162 participants (Anticipated)Interventional2020-10-08Recruiting
The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty[NCT03795649]80 participants (Anticipated)Interventional2018-12-18Recruiting
A Large Randomised Placebo Controlled Trial Among Trauma Patients With, or at Risk of, Significant Haemorrhage, of the Effects of Antifibrinolytic Treatment on Death and Transfusion Requirement[NCT00375258]Phase 320,211 participants (Actual)Interventional2005-05-31Completed
Tranexamic Acid to Prevent Bleeding After Endoscopic Resection of Large Colorectal Polyps: A Pilot Project[NCT04559880]Phase 425 participants (Actual)Interventional2020-09-10Active, not recruiting
A Multi-centre Randomised, Double-blinded, Placebo-controlled Trial of Pre-hospital Treatment With Tranexamic Acid for Severely Injured Patients at Risk of Acute Traumatic Coagulopathy.[NCT02187120]Phase 31,310 participants (Actual)Interventional2014-07-28Completed
Precise Application of Topical Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding: A Randomized Controlled Study[NCT05248321]60 participants (Actual)Interventional2022-03-24Completed
Evaluation of the Use of Tranexamic Acid in Tibial Osteotomies: a Randomised Controlled Clinical Trial.[NCT04785651]84 participants (Anticipated)Interventional2021-02-22Recruiting
Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage[NCT05554211]Phase 230 participants (Anticipated)Interventional2022-07-12Recruiting
The Effect of Local Tranexamic Acid on Post-operative Edema and Ecchymosis in Eyelid Surgery[NCT04951128]Phase 450 participants (Anticipated)Interventional2021-08-01Not yet recruiting
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial[NCT03364491]Phase 311,000 participants (Actual)Interventional2018-03-15Completed
Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma. A Double-blind, Placebo-controlled, Multicentre, Randomized Controlled Clinical Trial[NCT03582293]Phase 3140 participants (Anticipated)Interventional2018-06-19Recruiting
DEPOSITION: Pilot Study Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery[NCT03376061]Phase 497 participants (Actual)Interventional2017-12-21Completed
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) Study[NCT03954314]Phase 33,242 participants (Actual)Interventional2019-09-17Terminated (stopped due to Upon the Data Safety Monitoring Board review of the interim analysis (75% of participants have finished their follow-up) on November 17, 2023, they made a recommendation to stop recruitment into the trial.)
Prophylactic Use of Tranexamic Acid for Preventing Postpartum Hemorrhage: A Randomized, Double-blinded, Placebo-controlled Pilot Trial[NCT03069859]Phase 231 participants (Actual)Interventional2018-03-06Active, not recruiting
[NCT01938768]110 participants (Actual)Observational2013-11-30Completed
Peroperative Tranexamic Acid as Prophylaxis of Haemorrhage in Benign Hysterectomy - a Randomized, Placebo-controlled Trial[NCT01940419]Phase 4332 participants (Actual)Interventional2013-04-30Completed
IV Tranexamic Acid Prior to Hysterectomy for Reduction of Intraoperative Blood Loss: A Randomized Placebo-Controlled Trial[NCT02911831]Early Phase 171 participants (Actual)Interventional2016-11-30Completed
Range of Motion and Function Following Primary Repair of Traumatic Zone 1 or Zone 2 Digit Flexor Tendon Injuries - Impact of Tranexamic Acid Use - A Prospective Study[NCT04178655]Early Phase 148 participants (Anticipated)Interventional2019-11-30Not yet recruiting
The Effect of Tranexamic Acid on Blood Loss and Transfusion Rates in Major Oncologic Surgery[NCT01980355]76 participants (Actual)Interventional2012-06-12Completed
Comparative Study For Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section: A Randomised Controlled Trial[NCT02739815]Phase 4200 participants (Actual)Interventional2016-04-30Completed
Pre-hospital Administration of Tranexamic Acid for Adults With Moderate and Severe Traumatic Brain Injury: a Randomized, Double-blinded, Placebo-controlled Trial[NCT02645552]Phase 3400 participants (Anticipated)Interventional2016-01-31Not yet recruiting
Single Centre Randomised Controlled Trial to Assess the Effect of the Addition of Twenty-four Hours of Oral Tranexamic Acid Post-operatively to a Single Intra-operative Intravenous Dose of Tranexamic Acid on Calculated Blood Loss Following Primary Hip and[NCT03690037]Phase 41,089 participants (Actual)Interventional2016-07-07Completed
Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid Administration of Trauma Patients: A Randomized, Double-blind Controlled Clinical Trial[NCT03846973]Phase 3220 participants (Actual)Interventional2018-12-02Completed
Tranexamic Acid Versus Novel Uterine Cooling Technique in Reducing Blood Loss and Incidence of Postpartum Hemorrhage at Caesarean Section[NCT02780245]Phase 4100 participants (Actual)Interventional2016-06-30Completed
Blood Loss Reduction After Total Knee Arthroplasty. A Comparison Between Topical Tranexamic Acid and Platelet Rich Plasma: Controlled Clinical Trial[NCT02650856]Phase 340 participants (Actual)Interventional2015-09-30Completed
A Novel Technique Of Uterine Cooling During Repeated Cesarean Section For Reducing Blood Loss[NCT03793153]99 participants (Actual)Interventional2018-12-19Completed
The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery[NCT02684851]Phase 387 participants (Actual)Interventional2012-10-31Completed
The Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin / Hematocrit in Isolated Operative Posterior Wall Acetabular Fractures: a Prospective, Randomized, Double-blinded, Multicenter Study[NCT05357079]Early Phase 198 participants (Anticipated)Interventional2017-08-25Recruiting
Prevention of Postpartum Hemorrhage With Tranexamic Acid (TXA)[NCT03326596]Phase 41,000 participants (Anticipated)Interventional2018-04-20Recruiting
The Effects of the Timing of Tranexamic Acid Administration on Blood Loss in Hip Fractures.[NCT04488367]Early Phase 1120 participants (Anticipated)Interventional2020-07-06Recruiting
The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery[NCT01728636]Phase 261 participants (Actual)Interventional2013-01-15Completed
Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy: a Randomized, Double-blind, Placebo-controlled Trial[NCT05816668]Phase 3122 participants (Anticipated)Interventional2023-04-30Not yet recruiting
The Effect of Tranexamic Acid (TXA) on Blood Loss in Burn Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial[NCT03113253]Phase 4121 participants (Actual)Interventional2016-09-22Active, not recruiting
Role of Tranexamic Acid for Reducing Blood Loss in Patients Undergoing Major Gastro-intestinal Surgery[NCT01655641]Phase 2/Phase 3118 participants (Anticipated)Interventional2012-07-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Hemoglobin

[Key secondary outcome] Change in hemoglobin from the most recent measured before delivery to lowest measured in the 48 hours after delivery (NCT03364491)
Timeframe: from 4 weeks before delivery to 48 hours postpartum

Interventiongrams per deciliter (Mean)
Tranexamic Acid-1.8
Placebo-1.9

Length of Stay

Mother's length of stay from delivery to discharge (NCT03364491)
Timeframe: Until hospital discharge, an average of 3 days

Interventiondays (Median)
Tranexamic Acid3
Placebo3

Number of Mothers Who Died or Had Thromboembolic Events (Venous or Arterial), Ischemic Stroke, Myocardial Infarction, New-onset Seizure Activity, or Were Admitted to the Intensive Care Unit for More Than 24 Hours

(NCT03364491)
Timeframe: within 6 weeks postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid35
Placebo32

Number of Participants Who Received Open Label TXA or Other Antifibrinolytic

This is the number of mothers who were treated with any amount of open-label TXA (not blinded study drug) or another antifibrinolytic (eg., Amicar) (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid108
Placebo109

Number of Participants Who Received Surgical or Radiologic Interventions to Control Bleeding and Related Complications

This is the number of mothers who required any of the following types of surgical procedures to control bleeding: laparotomy, evacuation of hematoma, hysterectomy, uterine packing, intrauterine balloon tamponade, interventional radiology (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid233
Placebo231

Number of Participants Who Received Treatments and Interventions in Response to Bleeding and Related Complications

[Key secondary outcome] This is the number of mothers who received treatments and interventions to control bleeding such as: uterotonics such as prostaglandins or methergine, but excluding oxytocin; open label TXA or other antifibrinolytics; transfusion of 1 or more units of fresh frozen plasma, cryoprecipitate, or platelets or administration of any factor concentrates; laparotomy, evacuation of hematoma, hysterectomy, uterine packing, intrauterine balloon tamponade, interventional radiology (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid892
Placebo986

Number of Participants Who Were Transfused With 4 or More Units of Packed Red Blood Cells

Participants were categorized according to the amount of packed red blood cells or whole blood transfused, either as 0 to 3 units, or 4 or more units (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid20
Placebo19

Number of Participants Who Were Transfused With Other Blood Products

This is the number of mothers who received during the first 7 days after delivery a transfusion of 1 or more units of fresh frozen plasma, cryoprecipitate, or platelets, or received any factor concentrates (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid29
Placebo31

Number of Participants Who Were Treated With Uterotonics Other Than Oxytocin

This is the number of mothers who were treated with uterotonics such as prostaglandins or methergine, but excluding oxytocin, from delivery through 48 hours after delivery. (NCT03364491)
Timeframe: within 48 hours postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid649
Placebo732

Number of Participants With a Thromboembolic Event (Venous or Arterial), Ischemic Stroke, or Myocardial Infarction

[Key secondary outcome] This is the number of mothers who experienced a thromboembolic event, ischemic stroke, or myocardial infarction during the 6 weeks after delivery. (NCT03364491)
Timeframe: within 6 weeks postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid12
Placebo13

Number of Participants With Estimated Blood Loss Greater Than 1 Liter During Delivery

[Major secondary outcome] The surgeon or anesthesiologist estimated the blood loss during the delivery in milliliters, which was recorded in the anesthesia record and/or operative report (NCT03364491)
Timeframe: From skin incision to transfer from operating room, average of 1 hour

InterventionParticipants (Count of Participants)
Tranexamic Acid339
Placebo368

Number of Participants With Maternal Death or Transfusion of Packed Red Blood Cells

Participants were monitored from delivery until hospital discharge or 7 days after delivery (postpartum), whichever is sooner. This is the number of mothers who died for any reason, or had a blood transfusion of 1 or more units (of packed red blood cells, including whole blood or cell saver). (NCT03364491)
Timeframe: by hospital discharge or by 7 days postpartum, whichever is sooner

InterventionParticipants (Count of Participants)
Tranexamic Acid201
Placebo233

Number of Participants With Postpartum Infectious Complications

[Key Secondary Outcome] This is the number of mothers who experienced any of the following infectious complications in the 6 weeks after delivery: endometritis, surgical site infection, pelvic abscess (NCT03364491)
Timeframe: within 6 weeks postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid162
Placebo125

Number of Participants With Seizure Activity That Was Not Seen Prior to Study Enrollment

This is the number of mothers who experienced seizure activity, confirmed by central review, whose onset is after enrollment (NCT03364491)
Timeframe: within 6 weeks postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid2
Placebo0

Mean Concentration of TxA in Plasma Collected From Participants

Plasma TxA concentrations measured from blood samples taken upon arrival in the ICU (NCT03376061)
Timeframe: on arrival in ICU within 3 hours

Interventionmicrogram per milliliter per kilogram (Mean)
Topical TxA (Intervention)0.58
Intravenous TxA (Control)1.10

Median Number of Hours Participants Spent in ICU

Number of hours participants spent in the intensive care unit (ICU) (NCT03376061)
Timeframe: Number of hours spent in ICU from arrival to exit (collected at the Post-Operative Visit).

Interventionhours (Median)
Topical TxA (Intervention)23
Intravenous TxA (Control)26

Median Volume of Mediastinal Fluid Collected From Participants

Cumulative volume (mL) of fluid collected from mediastinal drainage tubes 24 hours after the surgical procedure (NCT03376061)
Timeframe: Fluid collected in the first 24 hours after the surgical procedure

InterventionmL (Median)
Topical TxA (Intervention)500
Intravenous TxA (Control)540

Number of Participants With Mortality

The occurrence of death due to any cause (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge

InterventionParticipants (Count of Participants)
Topical TxA (Intervention)1
Intravenous TxA (Control)1

Number of Participants With RBC Transfusion

Patients requiring a red blood cell transfusion (NCT03376061)
Timeframe: Intra-operative and post-operative RBC transfusions

InterventionParticipants (Count of Participants)
Topical TxA (Intervention)19
Intravenous TxA (Control)23

Number of Participants With Re-operation for Bleeding or Tamponade

Occurrence of re-operation for the purpose of bleeding or cardiac tamponade (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge

InterventionParticipants (Count of Participants)
Topical TxA (Intervention)0
Intravenous TxA (Control)1

Number of Participants With Seizures

Patients experiencing a post-operative seizure (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge

InterventionParticipants (Count of Participants)
Topical TxA (Intervention)0
Intravenous TxA (Control)1

Estimated Blood Loss

Surgical blood loss estimation (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge

InterventionmL (Median)
Tranexamic Acid450
Placebo365

Number of Participants Who Required Transfusion

To determine the impact of perioperative administration of tranexamic acid on blood loss and transfusion rates in major oncologic surgery (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge

InterventionParticipants (Count of Participants)
Tranexamic Acid8
Placebo5

Therapeutic Effect on Drainage Quantification

The blood quantification will be taken at 6am every day. (NCT02650856)
Timeframe: up to 2nd day post operative (24 and 48 hrs)

,
InterventionmL (Mean)
24 hours48 hours
Group 1 Tranexamic Acid246.4120.8
Group 2 Platelet Rich Plasma263.2140.2

Therapeutic Effect on Hematocrit Level

The blood test will be taken at 6am every day. Using the same laboratory parameters. (NCT02650856)
Timeframe: up to 3rd day post operative (Baseline, 24, 48 and 72hrs)

,
Interventionpercentage of Hematocrite (Mean)
Baseline24 hours48 hours72 hours
Group 1 Tranexamic Acid41.731.629.128.6
Group 2 Platelet Rich Plasma41.529.827.727.3

Therapeutic Effect on Hemoglobin Level

The blood test will be taken at 6am every day. Using the same laboratory parameters. (NCT02650856)
Timeframe: up to 3rd day post operative (Baseline, 24, 48 and 72hrs)

,
Interventiong/dL (Mean)
Baseline24 hours48 hours72 hours
Group 1 Tranexamic Acid13.610.39.59.3
Group 2 Platelet Rich Plasma13.69.99.29.1

Allogenic Blood Transfusion Rates

Number of participant received allogenic blood transfusions. (NCT02684851)
Timeframe: post-operative

InterventionParticipants (Count of Participants)
Tranexamic21
Placebo13

Estimate Blood Loss

To measure average estimate perioperative blood loss (NCT02684851)
Timeframe: perioperative

InterventionmL (Mean)
Tranexamic727.6
Placebo560.1

Number of Participants With a Thromboembolic Event

Do patients undergoing acetabular ORIF who receive tranexamic acid have a higher risk for thromboembolic events than patients who receive placebo? (NCT02684851)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Tranexamic1
Placebo0

Units of Packed Red Blood Cells Transfused

Average units packed red blood cells transfused among participants (NCT02684851)
Timeframe: perioperative

InterventionUnits of packed red blood cells (Mean)
Tranexamic2.65
Placebo2.36

Additional Blood Products Transfused

Total additional blood products (fresh frozen plasma, cryoprecipitate, and platelets) transfused in the perioperative period measured in units. (NCT01728636)
Timeframe: 24 hours after skin incision

InterventionUnits (Mean)
Tranexamic Acid1
Placebo2

Estimated Intraoperative Blood Loss

Estimated Intraoperative blood loss in milliliters (mLs) (NCT01728636)
Timeframe: Incision to skin closure (approximately 10 hours)

InterventionMilliliters (Mean)
Tranexamic Acid1550
Placebo1600

Post Operative Major Morbidity

Number of participants who experienced arterial or venous thromboembolism, neurologic complications (including stroke, seizure,and delirium), infections, and pulmonary renal or cardiac adverse outcomes (demand ischemia, myocardial infarction or new arrhythmia) before another operative procedure or hospital discharge. (NCT01728636)
Timeframe: Time of surgery to date of discharge from hospital (average 7 days)

InterventionParticipants (Count of Participants)
Tranexamic Acid9
Placebo9

Total Operating Room Time

Total operating room time from incision to closure of incision in minutes. (NCT01728636)
Timeframe: Minutes

InterventionMinutes (Median)
Tranexamic Acid602
Placebo576

Total Red Blood Cells Transfused in the Intraoperative Period

Total red blood cells transfused in the intraoperative period in (mL). Total RBC equal packed red blood cells and cell saver infusion. (NCT01728636)
Timeframe: Intraoperative period (approximately 12 hours)

Interventionmilliliters (Median)
Tranexamic Acid1140
Placebo1460

Total Tranexamic Acid Dose (mg)

Total milligrams of intravenous tranexamic acid administered during the surgical procedure. (NCT01728636)
Timeframe: Intraoperative period

Interventionmilligrams (Median)
Tranexamic Acid1408
Placebo0

Reviews

16 reviews available for tranexamic acid and Blood Clot

ArticleYear
Plasminogen: an enigmatic zymogen.
    Blood, 2021, 05-27, Volume: 137, Issue:21

    Topics: Animals; Antifibrinolytic Agents; Brain; Conjunctivitis; Enzyme Activation; Fibrin; Fibrinolysin; Fi

2021
The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: A systematic review and cumulative meta-analysis.
    Journal of clinical anesthesia, 2018, Volume: 44

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass, Off-Pump;

2018
'Massive transfusion protocols and the use of tranexamic acid'.
    Current opinion in hematology, 2018, Volume: 25, Issue:6

    Topics: Antifibrinolytic Agents; Blood Transfusion; Humans; Thrombosis; Tranexamic Acid

2018
Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis.
    Thrombosis research, 2019, Volume: 179

    Topics: Humans; Thrombosis; Tranexamic Acid

2019
Mortality and Thrombosis in Injured Adults Receiving Tranexamic Acid in the Post-CRASH-2 Era.
    The western journal of emergency medicine, 2019, Volume: 20, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Humans; Incidence; Mortality; Thrombosis; Tranexamic Acid; Trauma Se

2019
Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality.
    Prescrire international, 2013, Volume: 22, Issue:140

    Topics: Antifibrinolytic Agents; Hemorrhage; Humans; Severity of Illness Index; Thrombosis; Time Factors; Tr

2013
The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis.
    Transfusion medicine reviews, 2014, Volume: 28, Issue:3

    Topics: Aminocaproic Acid; Blood Loss, Surgical; Blood Transfusion; Gynecologic Surgical Procedures; Hemorrh

2014
The current place of tranexamic acid in the management of bleeding.
    Anaesthesia, 2015, Volume: 70 Suppl 1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Postpartum Hemorrhage; Thrombosis

2015
The current place of tranexamic acid in the management of bleeding.
    Anaesthesia, 2015, Volume: 70 Suppl 1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Postpartum Hemorrhage; Thrombosis

2015
The current place of tranexamic acid in the management of bleeding.
    Anaesthesia, 2015, Volume: 70 Suppl 1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Postpartum Hemorrhage; Thrombosis

2015
The current place of tranexamic acid in the management of bleeding.
    Anaesthesia, 2015, Volume: 70 Suppl 1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Postpartum Hemorrhage; Thrombosis

2015
The current place of tranexamic acid in the management of bleeding.
    Anaesthesia, 2015, Volume: 70 Suppl 1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Postpartum Hemorrhage; Thrombosis

2015
The current place of tranexamic acid in the management of bleeding.
    Anaesthesia, 2015, Volume: 70 Suppl 1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Postpartum Hemorrhage; Thrombosis

2015
The current place of tranexamic acid in the management of bleeding.
    Anaesthesia, 2015, Volume: 70 Suppl 1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Postpartum Hemorrhage; Thrombosis

2015
The current place of tranexamic acid in the management of bleeding.
    Anaesthesia, 2015, Volume: 70 Suppl 1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Postpartum Hemorrhage; Thrombosis

2015
The current place of tranexamic acid in the management of bleeding.
    Anaesthesia, 2015, Volume: 70 Suppl 1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Postpartum Hemorrhage; Thrombosis

2015
Manifestation of tranexamic acid toxicity in chronic kidney disease and kidney transplant patients: A report of four cases and review of literature.
    Nephrology (Carlton, Vic.), 2017, Volume: 22, Issue:4

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Blood Loss, Surgic

2017
Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery.
    Journal of anesthesia, 2010, Volume: 24, Issue:1

    Topics: Aminocaproic Acid; Animals; Antifibrinolytic Agents; Aprotinin; Cardiac Surgical Procedures; Cardiop

2010
Management of coagulation: an Australian perspective.
    Current opinion in anaesthesiology, 2012, Volume: 25, Issue:1

    Topics: Australia; Blood Coagulation Disorders; Factor VIIa; Hemorrhage; Humans; Perioperative Care; Platele

2012
The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials.
    Current drug safety, 2012, Volume: 7, Issue:1

    Topics: Adult; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Hemorrhage; Humans; Middle Aged;

2012
Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities.
    Shock (Augusta, Ga.), 2013, Volume: 39, Issue:2

    Topics: Antifibrinolytic Agents; Hemorrhage; Humans; Postoperative Complications; Randomized Controlled Tria

2013
Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2007, Volume: 7, Issue:1

    Topics: Adult; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Controlled Cl

2007
Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon-aminocaproic acid.
    International anesthesiology clinics, 1995,Winter, Volume: 33, Issue:1

    Topics: Aminocaproic Acid; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Procedures; Graft Occlusion, Va

1995
Aprotinin in patients having coronary artery bypass graft surgery.
    Current opinion in cardiology, 1995, Volume: 10, Issue:6

    Topics: Aprotinin; Coronary Artery Bypass; Creatinine; Deamino Arginine Vasopressin; Drug Hypersensitivity;

1995

Trials

17 trials available for tranexamic acid and Blood Clot

ArticleYear
Tranexamic Acid in Patients Undergoing Noncardiac Surgery.
    The New England journal of medicine, 2022, 05-26, Volume: 386, Issue:21

    Topics: Antifibrinolytic Agents; Canada; Hemorrhage; Humans; Surgical Procedures, Operative; Thrombosis; Tra

2022
Effect of High- vs Low-Dose Tranexamic Acid Infusion on Need for Red Blood Cell Transfusion and Adverse Events in Patients Undergoing Cardiac Surgery: The OPTIMAL Randomized Clinical Trial.
    JAMA, 2022, 07-26, Volume: 328, Issue:4

    Topics: Adult; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Dose-Response R

2022
[Efficacy and safety of multiple-dose intravenous tranexamic acid for reducing blood loss in complex tibial plateau fractures: A prospective randomized controlled trial].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2023, Sep-15, Volume: 37, Issue:9

    Topics: Blood Loss, Surgical; Humans; Interleukin-6; Prospective Studies; Thrombosis; Tibial Fractures; Tibi

2023
Effect of Tranexamic Acid on Coagulation and Fibrin Clot Properties in Children Undergoing Craniofacial Surgery.
    Thrombosis and haemostasis, 2020, Volume: 120, Issue:3

    Topics: Blood Coagulation; Child; Child, Preschool; Craniosynostoses; Factor XIII; Female; Fibrin Clot Lysis

2020
Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial.
    International orthopaedics, 2020, Volume: 44, Issue:10

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Humans; Prospective Studies; Rivar

2020
Intra-articular Application is More Effective Than Intravenous Application of Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:11

    Topics: Administration, Intravenous; Adult; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee;

2017
Tranexamic Acid Decreases Visible and Hidden Blood Loss Without Affecting Prethrombotic State Molecular Markers in Transforaminal Thoracic Interbody Fusion for Treatment of Thoracolumbar Fracture-Dislocation.
    Spine, 2018, 07-01, Volume: 43, Issue:13

    Topics: Adult; Antifibrinolytic Agents; Biomarkers; Blood Loss, Surgical; Double-Blind Method; Female; Fract

2018
Application of thrombelastography (TEG) for safety evaluation of tranexamic acid in primary total joint arthroplasty.
    Journal of orthopaedic surgery and research, 2019, Jul-15, Volume: 14, Issue:1

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Ar

2019
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Confidence Intervals; Craniocerebral Trauma; Fema

2013
Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trial.
    Archives of orthopaedic and trauma surgery, 2015, Volume: 135, Issue:4

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Dose-Response Rel

2015
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 01-12, Volume: 376, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass

2017
Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:8

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical Procedu

2017
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tra

2010
Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients.
    Orthopaedics & traumatology, surgery & research : OTSR, 2012, Volume: 98, Issue:5

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bone Cements; Case-Co

2012
Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial.
    BMJ (Clinical research ed.), 2012, Sep-11, Volume: 345

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Drug Administration Schedule; Female; Hemor

2012
[The use of antifibrinolytics in heart surgery. 3 prospective studies].
    Cahiers d'anesthesiologie, 1993, Volume: 41, Issue:5

    Topics: Antifibrinolytic Agents; Aprotinin; Blood Platelets; Cardiac Surgical Procedures; Creatinine; Double

1993
Treatment with the fibrinolytic inhibitor tranexamic acid--risk for thrombosis?
    Acta obstetricia et gynecologica Scandinavica, 1990, Volume: 69, Issue:4

    Topics: Female; Humans; Thrombosis; Tranexamic Acid; Uterine Cervical Diseases

1990

Other Studies

71 other studies available for tranexamic acid and Blood Clot

ArticleYear
Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:10

    Topics: Animals; Antifibrinolytic Agents; Aprotinin; Arteriovenous Shunt, Surgical; Blood Coagulation; Dose-

2007
Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models.
    PloS one, 2021, Volume: 16, Issue:10

    Topics: Animals; Arteries; Blood Coagulation Factors; Factor VIIa; Female; Hemodilution; Rabbits; Rats, Spra

2021
Circulation collapse caused by intracardiac thrombosis associated with tranexamic acid administration: A case report.
    Medicine, 2021, Nov-24, Volume: 100, Issue:47

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Circulation; Blood Loss, Surgical; C

2021
Tranexamic acid-induced ureteric clot obstruction in a patient with urothelial cell carcinoma resulting in upper urinary tract perforation.
    BMJ case reports, 2022, Jan-17, Volume: 15, Issue:1

    Topics: Aged; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Thrombosis; Tranexamic Acid; U

2022
The role of tranexamic acid in traumatic brain injury.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2022, Volume: 99

    Topics: Antifibrinolytic Agents; Brain Injuries, Traumatic; Fibrinolysis; Humans; Thrombosis; Tranexamic Aci

2022
Removal of airway obstruction due to presence of blood clots and the role of tranexamic acid - case report.
    Anaesthesiology intensive therapy, 2022, Volume: 54, Issue:2

    Topics: Airway Obstruction; Humans; Respiration, Artificial; Suction; Thrombosis; Tranexamic Acid

2022
Tranexamic Acid Use During Surgery Associated with Extension of Acute Perioperative Type 1 Myocardial Infarction: A Case Report.
    JBJS case connector, 2022, 04-01, Volume: 12, Issue:2

    Topics: Aged; Biomarkers; Female; Femoral Artery; Humans; Myocardial Infarction; Thrombosis; Tranexamic Acid

2022
[PERIOPERATIVE MANAGEMENT OF AN ADOLESCENT GIRL WITH SEVERE FACTOR XI DEFICIENCY AND INHIBITORS].
    Harefuah, 2023, Volume: 162, Issue:1

    Topics: Adolescent; Factor XI Deficiency; Female; Hemorrhage; Humans; Pregnancy; Pregnancy Complications, He

2023
Characteristics and Outcomes of Liver Transplantation Recipients after Tranexamic Acid Treatment and Platelet Transfusion: A Retrospective Single-Centre Experience.
    Medicina (Kaunas, Lithuania), 2023, Jan-23, Volume: 59, Issue:2

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Cohort Studies; Humans; Liver Transplantation; Platel

2023
Tranexamic acid as a novel adjunct in the management of vessel perforation complicating Endovascular Clot Retrieval.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2023, Volume: 32, Issue:6

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Case-Control Studies; Hemorrhage; Humans; Retrospecti

2023
Tranexamic acid does not cause clots: experience in carotid endarterectomy.
    The British journal of surgery, 2023, 07-17, Volume: 110, Issue:8

    Topics: Carotid Stenosis; Endarterectomy; Endarterectomy, Carotid; Humans; Thrombosis; Tranexamic Acid

2023
Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery.
    Thrombosis and haemostasis, 2019, Volume: 119, Issue:12

    Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Drug Administration Schedule; Factor VII

2019
Prothrombin Complex Concentrate before Urgent Surgery in Patients Treated with Rivaroxaban and Apixaban.
    Acta haematologica, 2020, Volume: 143, Issue:3

    Topics: Academic Medical Centers; Aged; Aged, 80 and over; Atrial Fibrillation; Blood Coagulation Factors; B

2020
Review: In nonsurgical settings, tranexamic acid reduces mortality and does not increase thrombotic events.
    Annals of internal medicine, 2019, 10-15, Volume: 171, Issue:8

    Topics: Humans; Thrombosis; Tranexamic Acid

2019
Tranexamic acid in vascular surgery: antifibrinolytic or clot-stabilising activity.
    British journal of anaesthesia, 2020, Volume: 124, Issue:1

    Topics: Antifibrinolytic Agents; Aortic Aneurysm; Humans; Thrombosis; Tranexamic Acid; Vascular Surgical Pro

2020
Effect of Tranexamic Acid for Traumatic Brain Injury: A Case Report.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2020, Sep-09, Volume: 87, Issue:4

    Topics: Aged, 80 and over; Antifibrinolytic Agents; Blood Coagulation; Blood Coagulation Disorders; Brain In

2020
Safety of tranexamic acid in thrombotic adverse events and seizure in patients with haemorrhage: a protocol for a systematic review and meta-analysis.
    BMJ open, 2020, 06-22, Volume: 10, Issue:6

    Topics: Antifibrinolytic Agents; Hemorrhage; Humans; Meta-Analysis as Topic; Patient Safety; Systematic Revi

2020
Acute oxygenator occlusion in two cases of polycythemia vera: Bailout strategies.
    Journal of cardiac surgery, 2020, Volume: 35, Issue:10

    Topics: Acute Disease; Aortic Valve; Aortic Valve Stenosis; Blood Coagulation; Female; Heparin; Humans; Male

2020
Administration of tranexamic acid during total shoulder arthroplasty is not associated with increased risk of complications in patients with a history of thrombotic events.
    Journal of shoulder and elbow surgery, 2021, Volume: 30, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Shoulder; Blood Loss, Surgical; Databases,

2021
Tranexamic acid in traumatic brain injury.
    The Medical journal of Malaysia, 2020, Volume: 75, Issue:6

    Topics: Antifibrinolytic Agents; Brain Injuries, Traumatic; Humans; Prospective Studies; Thrombosis; Tranexa

2020
Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data.
    European journal of clinical pharmacology, 2021, Volume: 77, Issue:6

    Topics: Adolescent; Adult; Antifibrinolytic Agents; Databases, Factual; Embolism; Female; Humans; Ischemia;

2021
Letter to the editor on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial
    International orthopaedics, 2021, Volume: 45, Issue:5

    Topics: Antifibrinolytic Agents; Humans; Prospective Studies; Rivaroxaban; Thrombosis; Tranexamic Acid

2021
Comment on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial".
    International orthopaedics, 2021, Volume: 45, Issue:7

    Topics: Antifibrinolytic Agents; Humans; Prospective Studies; Rivaroxaban; Thrombosis; Tranexamic Acid

2021
Response to letter to the editor and comment concerning "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratifi
    International orthopaedics, 2021, Volume: 45, Issue:8

    Topics: Antifibrinolytic Agents; Humans; Prospective Studies; Rivaroxaban; Thrombosis; Tranexamic Acid

2021
Aortoiliac Thrombosis Following Tranexamic Acid Administration During Urgent Cesarean Hysterectomy: A Case Report.
    A & A case reports, 2017, Aug-01, Volume: 9, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Aorta, Abdominal; Balloon Occlusion; Cesarean Section; Female; Human

2017
Endogenous fibrinolysis facilitates clot retraction in vivo.
    Blood, 2017, 12-07, Volume: 130, Issue:23

    Topics: Actomyosin; Animals; Blood Platelets; Clot Retraction; Fibrin; Fibrinolysis; Humans; Male; Mice; Non

2017
Fibrinolysis in Living Donor Liver Transplantation Recipients Evaluated Using Thromboelastometry: Impact on Mortality.
    Transplantation proceedings, 2017, Volume: 49, Issue:9

    Topics: Adult; Aged; Antifibrinolytic Agents; Female; Fibrinolysis; Hepatic Artery; Humans; Incidence; Liver

2017
Tranexamic Acid Dosing for Cardiac Surgical Patients With Chronic Renal Dysfunction: A New Dosing Regimen.
    Anesthesia and analgesia, 2018, Volume: 127, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Drug Administrat

2018
Left atrial thrombi following tranexamic acid in a bleeding trauma patient-A word of caution.
    Journal of cardiac surgery, 2018, Volume: 33, Issue:2

    Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Female; Heart Atria; Heart Diseases; Hemorrhage; Hep

2018
Tranexamic Acid in Pertrochanteric Femoral Fracture: Is it a Safe Drug or Not?
    Folia medica, 2018, Mar-01, Volume: 60, Issue:1

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Transfusion; Female; Fracture Fixation, Intr

2018
Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis.
    BMC musculoskeletal disorders, 2018, Jul-18, Volume: 19, Issue:1

    Topics: Administration, Topical; Aged; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2018
Ulnar Artery Thrombosis Following Tranexamic Acid Administration for Craniosynostosis Repair.
    The Journal of craniofacial surgery, 2019, Volume: 30, Issue:1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Child, Preschool; Craniosynostoses; Female; Humans; T

2019
A delicate balance: Bleeding versus thrombosis?
    The Journal of thoracic and cardiovascular surgery, 2019, Volume: 157, Issue:2

    Topics: Aspirin; Coronary Artery Bypass; Hemorrhage; Humans; Thrombosis; Tranexamic Acid

2019
Postoperative thrombotic effects of tranexamic acid in open heart surgery.
    Irish journal of medical science, 2019, Volume: 188, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Ca

2019
Acute ST-elevation myocardial infarction due to in-stent thrombosis after administering tranexamic acid in a high cardiac risk patient.
    BMJ case reports, 2019, Apr-08, Volume: 12, Issue:4

    Topics: Antifibrinolytic Agents; Drug-Eluting Stents; Humans; Male; Middle Aged; Risk Factors; ST Elevation

2019
Does Tranexamic Acid Affect Risk of Venous and Arterial Thrombosis or Mortality in Nonsurgical Patients?
    Annals of emergency medicine, 2020, Volume: 75, Issue:4

    Topics: Antifibrinolytic Agents; Humans; Thrombosis; Tranexamic Acid

2020
[Intravenous administration of tranexamic acid to decrease bleeding and transfusion in knee and hip prosthetic surgery: is it safe and cost-effective?].
    Medicina clinica, 2013, Sep-07, Volume: 141, Issue:5

    Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Cost-Benefit

2013
Tranexamic acid and thrombosis.
    Prescrire international, 2013, Volume: 22, Issue:140

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Female; Hematuria; Hemorrhage; Humans; Menorrhagia; R

2013
Trauma and tranexamic acid.
    The Medical journal of Australia, 2013, Sep-02, Volume: 199, Issue:5

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Thrombosis; Tranexamic Acid; Woun

2013
Tranexamic acid reduced mortality in trauma patients who were bleeding or at risk for bleeding.
    Annals of internal medicine, 2013, Sep-17, Volume: 159, Issue:6

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage; Humans; Male; Thrombosis; Tranexamic

2013
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

    Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocol

2014
TXA in combat casualty care--does it adversely affect extremity reconstruction and flap thrombosis rates?
    Military medicine, 2015, Volume: 180, Issue:3 Suppl

    Topics: Adult; Antifibrinolytic Agents; Arm Injuries; Female; Follow-Up Studies; Free Tissue Flaps; Humans;

2015
Left ventricle thrombus after tranexamic acid for spine surgery in an HIV-positive patient.
    The spine journal : official journal of the North American Spine Society, 2016, Volume: 16, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Heart Diseases; Heart Ventricles; HIV Infections; Humans; Male; Neuro

2016
Yet Another Tranexamic Acid-Related Thrombotic Complication.
    Journal of cardiothoracic and vascular anesthesia, 2016, Volume: 30, Issue:3

    Topics: Antifibrinolytic Agents; Humans; Thrombosis; Tranexamic Acid

2016
Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2016, Volume: 22, Issue:5

    Topics: Antifibrinolytic Agents; Clinical Trials as Topic; Coagulants; Databases, Factual; Dose-Response Rel

2016
Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
    Thrombosis and haemostasis, 2009, Volume: 102, Issue:3

    Topics: Alleles; Blood Loss, Surgical; Factor VIIa; Factor XI; Factor XI Deficiency; Female; Hemophilia A; H

2009
Tranexamic acid for trauma.
    Lancet (London, England), 2010, Sep-25, Volume: 376, Issue:9746

    Topics: Antifibrinolytic Agents; Hemorrhage; Humans; Randomized Controlled Trials as Topic; Selection Bias;

2010
Blood conservation and pain control in scoliosis corrective surgery: an online survey of UK practice.
    Paediatric anaesthesia, 2011, Volume: 21, Issue:1

    Topics: Adolescent; Analgesia, Epidural; Analgesics, Opioid; Anesthesia; Anticoagulants; Antifibrinolytic Ag

2011
Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2011, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Aged; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Fibr

2011
Görög Thrombosis Test: a global in-vitro test of platelet function and thrombolysis.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:1

    Topics: Adult; Antifibrinolytic Agents; Clot Retraction; Cytochalasin B; Dose-Response Relationship, Drug; F

2003
Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model.
    Thrombosis and haemostasis, 2003, Volume: 89, Issue:5

    Topics: Animals; Antibodies; Arginine; Drug Antagonism; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Kal

2003
Acute renal cortex necrosis caused by arterial thrombosis during treatment for acute promyelocytic leukemia.
    Haematologica, 2003, Volume: 88, Issue:6

    Topics: Acute Kidney Injury; Adult; Antifibrinolytic Agents; Antineoplastic Agents; Female; Humans; Kidney C

2003
About dosage schemes and safety of tranexamic acid in cardiac surgery.
    Anesthesiology, 2003, Volume: 99, Issue:1

    Topics: Antifibrinolytic Agents; Cardiac Surgical Procedures; Humans; Thrombosis; Tranexamic Acid

2003
Tranexamic acid and coronary surgery.
    Anesthesia and analgesia, 2004, Volume: 98, Issue:1

    Topics: Antifibrinolytic Agents; Cardiac Surgical Procedures; Coronary Vessels; Humans; Intraoperative Compl

2004
Synergistic antithrombotic effect of a combination of NO donor and plasma kallikrein inhibitor.
    Thrombosis research, 2005, Volume: 116, Issue:5

    Topics: Adult; Aged; Blood Platelets; Drug Synergism; Female; Fibrinolytic Agents; Humans; In Vitro Techniqu

2005
Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Anesthesia and analgesia, 2006, Volume: 103, Issue:6

    Topics: Aminocaproic Acid; Animals; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Procedures; Drug Hyper

2006
Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas.
    The American journal of surgical pathology, 2007, Volume: 31, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Humans; Infarction; Leiomyoma; Meno

2007
Ultrastructural study of the effects of tranexamic acid and urokinase on metastasis of Lewis lung carcinoma.
    British journal of cancer, 1982, Volume: 46, Issue:3

    Topics: Animals; Blood Platelets; Cyclohexanecarboxylic Acids; Endopeptidases; Fibrin; Lung Neoplasms; Male;

1982
Dextran's antithrombotic properties in small arteries are not altered by low-molecular-weight heparin or the fibrinolytic inhibitor tranexamic acid: an experimental study.
    Microsurgery, 1993, Volume: 14, Issue:4

    Topics: Animals; Arteries; Bleeding Time; Dextrans; Dose-Response Relationship, Drug; Ear, External; Fibrino

1993
Microscopic haematuria as a relative contraindication for tranexamic acid.
    British journal of haematology, 1995, Volume: 89, Issue:3

    Topics: Adult; Contraindications; Female; Hematuria; Hemorrhagic Disorders; Humans; Male; Middle Aged; Throm

1995
Inhibitory effects of lysine analogues on t-PA induced whole blood clot lysis.
    Thrombosis research, 1994, Mar-15, Volume: 73, Issue:6

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Humans; Reference Values; Thrombosis; Tissue Plasminogen

1994
Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin.
    Thrombosis and haemostasis, 1996, Volume: 75, Issue:1

    Topics: Animals; Antifibrinolytic Agents; Batroxobin; Endotoxins; Fibrinolytic Agents; Hemodynamics; Hydroge

1996
Prolonged arterial occlusion caused by thrombus development at sites of arterial bifurcation.
    Japanese circulation journal, 1997, Volume: 61, Issue:5

    Topics: Aminocaproic Acid; Animals; Antifibrinolytic Agents; Blood Platelets; In Vitro Techniques; Male; Mes

1997
Influence of early fibrinolysis inhibition on thrombus formation following microvascular trauma.
    Microsurgery, 1996, Volume: 17, Issue:5

    Topics: Anastomosis, Surgical; Animals; Antifibrinolytic Agents; Arteries; Ear; Male; Rabbits; Thrombolytic

1996
Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:5

    Topics: Animals; Antifibrinolytic Agents; Antithrombins; Arterial Occlusive Diseases; Aspirin; Blood Platele

1999
Con: the routine use of aprotinin during pediatric cardiac surgery is not a benefit.
    Journal of cardiothoracic and vascular anesthesia, 1999, Volume: 13, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Child; C

1999
All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia.
    British journal of haematology, 2000, Volume: 110, Issue:4

    Topics: Adult; Antifibrinolytic Agents; Antineoplastic Agents; Contraindications; Drug Therapy, Combination;

2000
Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation.
    Anesthesia and analgesia, 2001, Volume: 93, Issue:2

    Topics: Antifibrinolytic Agents; Erythrocyte Transfusion; Humans; Incidence; Liver Transplantation; Thrombos

2001
Lymphokines and thrombosis. Thrombocyte and coagulation activation by culture supernatants of concanavalin-A-stimulated human lymphocytes. Some physicochemical properties and inhibition by chemical compounds.
    Scandinavian journal of haematology. Supplementum, 1979, Volume: 34

    Topics: Adult; Aprotinin; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Concanavalin A; Dipyri

1979
Importance of fibrinolysis in limiting thrombus formation following severe microarterial trauma: an experimental study in the rabbit.
    Microsurgery, 1991, Volume: 12, Issue:5

    Topics: Animals; Arteries; Blood Coagulation; Blood Coagulation Tests; Fibrinolysis; Microscopy, Electron, S

1991
Acquired C1 esterase inhibitor deficiency.
    Anaesthesia, 1986, Volume: 41, Issue:8

    Topics: Angioedema; Complement C1 Inactivator Proteins; Female; Humans; Mesenteric Vascular Occlusion; Middl

1986